博济医药(300404.SZ)拟减持不超266.7万股的已回购股份

Group 1 - The core point of the article is that Boji Pharmaceutical (300404.SZ) announced a share repurchase plan to maintain company value and shareholder rights, with a maximum reduction of 2.667 million shares, representing 0.69% of the total share capital [1] Group 2 - The fifth board meeting of the company was held on February 24, 2026, where the share repurchase plan was approved [1] - The share repurchase will be conducted through centralized bidding [1] - The plan aligns with the company's previously disclosed repurchase report dated February 6, 2024 [1]